July 14, 2018 - The case was voluntarily dismissed.

August 28, 2017 - An investor in shares of Vitamin Shoppe Inc (NYSE: VSI) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Vitamin Shoppe Inc in connection with certain allegedly false and misleading statements made between March 1, 2017 and August 6, 2017.

According to the complaint the plaintiff alleges on behalf of purchasers of Vitamin Shoppe Inc (NYSE: VSI) common shares between March 1, 2017 and August 6, 2017, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 1, 2017 and August 6, 2017, the defendant failed to disclose that the Company’s retail segment was continuing to dramatically decline, as its ongoing “reinvention plan” was not meeting with success; ongoing changes to the Company’s operating plan brought about through the “reinvention plan” had already rendered the more than $168 million in goodwill being carried on Vitamin Shoppe Inc’s books for the retail segment impaired and Vitamin Shoppe Inc was improperly delaying recognizing that impairment charge; and as a result of the foregoing, defendants lacked a reasonable basis for their positive statements about Vitamin Shoppe Inc’s financial prospects, including the viability of its return to profitability during fiscal 2017, and the success of its reinvention plan.

Secaucus, NJ based Vitamin Shoppe Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. On March 1, 2017, Vitamin Shoppe Inc announced its fourth quarter 2016 results. Vitamin Shoppe Inc reported that its annual Total Revenue rose from over $1.26 billion in 2015 to over $1.28 billion in 2016. Vitamin Shoppe Inc also issued its outlook for 2017. Vitamin Shoppe Inc stated that it was on track to deliver fully diluted earnings per share in the range of $1.95 - $2.20 for FY17.

On May 10, 2017, Vitamin Shoppe Inc announced its first quarter 2017 results. Vitamin Shoppe Inc reported a 45% reduction in FY17 EPS guidance.

On August 9, 2017, Vitamin Shoppe Inc announced its second quarter 2017 results. Vitamin Shoppe Inc said that it was taking a $168 million goodwill impairment charge and would report a GAAP loss of $6.73 per share in the second quarter of 2017. Vitamin Shoppe Inc (NYSE: VSI) declined from as high as $47.19 per share in early 2015 to as low as $5.70 per share on August 21, 2017.